iRay Group (688301) Stock Overview
Researches, develops, produces, sells, and services x-ray system components for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
688301 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
iRay Group Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥102.30 |
| 52 Week High | CN¥126.00 |
| 52 Week Low | CN¥66.56 |
| Beta | 0.27 |
| 1 Month Change | -10.58% |
| 3 Month Change | -8.42% |
| 1 Year Change | 26.82% |
| 3 Year Change | -41.09% |
| 5 Year Change | 44.21% |
| Change since IPO | 75.33% |
Recent News & Updates
Recent updates
iRay Technology (SHSE:688301) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10
Investors Continue Waiting On Sidelines For iRay Technology Company Limited (SHSE:688301)
Dec 30Is iRay Technology (SHSE:688301) A Risky Investment?
Nov 18iRay Technology Company Limited (SHSE:688301) Soars 25% But It's A Story Of Risk Vs Reward
Sep 28iRay Technology (SHSE:688301) Might Be Having Difficulty Using Its Capital Effectively
Sep 27iRay Technology's (SHSE:688301) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 26iRay Technology Company Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next
Apr 23Are iRay Technology Company Limited (SHSE:688301) Investors Paying Above The Intrinsic Value?
Apr 11Slowing Rates Of Return At iRay Technology (SHSE:688301) Leave Little Room For Excitement
Mar 21With iRay Technology Company Limited (SHSE:688301) It Looks Like You'll Get What You Pay For
Feb 28Shareholder Returns
| 688301 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -4.4% | -3.3% | -1.5% |
| 1Y | 26.8% | -4.3% | 18.3% |
Return vs Industry: 688301 exceeded the CN Medical Equipment industry which returned -4.3% over the past year.
Return vs Market: 688301 exceeded the CN Market which returned 18.3% over the past year.
Price Volatility
| 688301 volatility | |
|---|---|
| 688301 Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 9.3% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 688301 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688301's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 2,093 | Tieer Gu | www.iraygroup.com |
iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-ray sources; high voltage generators; radiation detecting materials; software; and other products. It also engages in technology and product development; customer service; and investment and management activities.
iRay Group Fundamentals Summary
| 688301 fundamental statistics | |
|---|---|
| Market cap | CN¥21.60b |
| Earnings (TTM) | CN¥545.59m |
| Revenue (TTM) | CN¥2.02b |
Is 688301 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688301 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.02b |
| Cost of Revenue | CN¥1.03b |
| Gross Profit | CN¥994.64m |
| Other Expenses | CN¥449.05m |
| Earnings | CN¥545.59m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.58 |
| Gross Margin | 49.14% |
| Net Profit Margin | 26.95% |
| Debt/Equity Ratio | 60.9% |
How did 688301 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/20 19:07 |
| End of Day Share Price | 2025/11/20 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
iRay Group is covered by 20 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiongyi Hu | China International Capital Corporation Limited |
| Zhu Chen | Citic Securities Co., Ltd. |
| Lingpeng Zeng | Citic Securities Co., Ltd. |